Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

NeoRx reaches milestone in Biostent development

June 4, 1997

Anti E- and P-selectin antibodies from PDL

June 4, 1997

Comparative studies reported for treatment of paroxysmal atrial fibrillation

June 3, 1997

Tanabe Seiyaku reveals new ET antagonists

June 3, 1997

Mechanism of antiarrhythmic effect of UK-14304

June 2, 1997

Clinical electrophysiological and hemodynamic effects of BRL-32872A

June 2, 1997

New i.v. formulation of amiodarone better tolerated in patients

June 2, 1997

AMBI reports positive results for Cardia Salt Alternative

June 2, 1997

Carvedilol approved by FDA for CHF

May 30, 1997

New agents for atherosclerosis from Bayer

May 30, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...